Strata Critical Medical, Inc. · Healthcare · Medical Care Facilities
Scores & Status Key
AI Summary Scores: Intraday / Swing / Long scores are synthesized from multi-factor analysis for each timeframe. They summarize current conditions discussed in the report and do not constitute trading recommendations.
Intraday Trend Score: A 0–100 composite from the Trend Explorer™ analytics engine used for ranking and comparison. It describes current conditions and is not a forecast.
Trend Status: A rules-based label (Bullish / Mixed / Bearish) derived from signal confluence (trend structure, momentum, and positioning). It indicates alignment, not expected return.
At close
$4.21
−$0.07 (−1.59%) Close
Pre-market$4.35
+$0.14 (+3.28%) 7:52 AM ET
Prev closePrevC$4.28
OpenOpen$4.31
Day highHigh$4.31
Day lowLow$4.21
VolumeVol17
Avg volAvgVol827,331
On chart
Interval
Intervals apply to 1D & 5D.
Intervals apply to 1D & 5D.
Scale: Linear
Overlays
Panels
Style
Scale: Linear
Presets
Tools
Tickers only (no ^ indexes). Add up to 5.
Mkt cap
$369.65M
P/E ratio
8.60
FY Revenue
$312.67M
EPS
0.49
Gross Margin
24.20%
Sector
Healthcare
AI report sections
MIXED
SRTA
Strata Critical Medical, Inc.
SRTA exhibits firm upward price momentum near the top of its 52-week range supported by multiple bullish technical signals, but overbought momentum readings indicate elevated near-term pullback risk. Fundamentally, the company delivers positive net income and double-digit net margin while operating income and free cash flow remain negative, pointing to an earnings–cash flow disconnect. Short interest is non-trivial with days-to-cover elevated, yet the news backdrop is predominantly positive around growth strategy and leadership additions.
AI summarized at 4:09 PM ET, 2026-01-06
AI summary scores
INTRADAY:68SWING:72LONG:54
Volume vs average
Intraday (cumulative)
−5% (Below avg)
Vol/Avg: 0.95×
RSI
42.99(Neutral)
Neutral (40–60)
0255075100
MACD momentum
Intraday
+0.00 (Strong)
MACD: 0.00 Signal: 0.00
Short-Term
-0.01 (Weak)
MACD: -0.20 Signal: -0.19
Long-Term
-0.05 (Weak)
MACD: -0.17 Signal: -0.12
Intraday trend score
45.74
LOW45.74HIGH68.74
Latest news
SRTA•6 articles•Positive: 4Neutral: 2Negative: 0
NeutralGlobeNewswire Inc.• Not Specified
Strata Critical Medical Schedules Fourth Quarter 2025 Earnings Conference Call
Strata Critical Medical (Nasdaq: SRTA) announced it will release fourth quarter 2025 financial results on March 3, 2026, followed by a conference call at 8:00 am ET hosted by Co-CEOs Will Heyburn and Melissa Tomkiel. The company is a time-critical logistics and medical services provider specializing in organ transplant networks and surgical services.
The article is a routine earnings announcement with standard procedural information about financial results release and conference call details. No material business developments, performance metrics, or forward-looking statements are provided that would indicate positive or negative sentiment.
PositiveGlobeNewswire Inc.• Melissa Tomkiel And Will Heyburn
Strata Critical Medical, Inc. Appoints Will Cook to Board of Directors
Strata Critical Medical has appointed Will Cook, President and CEO of Vail Health, to its Board of Directors. Cook brings extensive healthcare leadership experience from roles at University of Colorado Hospital, UPMC, and Johns Hopkins Health System.
Company is expanding board expertise by adding a seasoned healthcare executive with strong industry relationships
PositiveGlobeNewswire Inc.• Will Heyburn And Melissa Tomkiel (Co-Ceos)
Strata Critical Medical Hosts 2025 Investor Day; Provides 2026 and Medium-Term Financial Guidance
Strata Critical Medical outlined its growth strategy at its 2025 Investor Day, targeting high-teens organic Adjusted EBITDA growth and planning $200 million in potential acquisitions through 2029 in the transplant industry logistics market.
Company presented strong growth targets, plans for strategic acquisitions, projected organic EBITDA doubling by 2029, and demonstrated confidence in market positioning
PositiveGlobeNewswire Inc.• Mathew Schneider
Strata Announces 2025 Investor Day
Strata Critical Medical, a time-critical logistics and medical services provider, announced its acquisition of Keystone Perfusion to expand its organ recovery platform. The acquisition is expected to generate approximately $65 million in revenue and $13 million in Adjusted EBITDA for the full year 2025.
Company is expanding its service offerings, acquiring a complementary business with strong revenue growth potential
PositiveBenzinga• Globe Newswire
Strata Acquires Keystone Perfusion, Creating Integrated Organ Recovery Platform, Diversifying into Other Medical Services
Strata Critical Medical has acquired Keystone Perfusion Services for $124 million, expanding its medical services platform and creating a comprehensive organ transplant service provider with capabilities in surgical recovery, logistics, and perfusion services.
Company is strategically diversifying its services, acquiring a profitable business with strong growth potential, and expanding into new medical market segments
Global Latex Pillow Market Size To Worth USD 810.2 Million By 2033 | CAGR OF 6.98%
The global latex pillow market is expected to grow from $412.7 million in 2023 to $810.2 million by 2033, driven by increasing musculoskeletal problems and new product designs. The blended mix segment and residential application are expected to lead the market.
The company is mentioned as one of the key vendors in the latex pillow market, but no additional information is provided about its performance or outlook.
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks App
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal
